Infosys, Richardson Electronics And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Infosys Limited (NYSE:INFY) to report quarterly earnings at 18 cents per share on revenue of $4.63 billion before the opening bell. Infosys shares fell 0.4% to $18.03 in after-hours trading.
  • KB Home (NYSE:KBH) reported upbeat earnings for its fourth quarter, but said homes delivered fell 10% to 3,407 in the three months ended Nov. 30, 2023. KB Home shares fell 1.1% to $62.50 in the after-hours trading session.
  • Analysts are expecting Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) to earn 18 cents per share on revenue of $119.69 million for the latest quarter. The company will release earnings after the markets close. Concrete Pumping shares rose 0.4% to close at $7.93 on Wednesday.

Check out our premarket coverage here

  • Richardson Electronics, Ltd. (NASDAQ:RELL) posted weaker-than-expected results for its second quarter. Richardson Electronics shares dipped 13% to $10.87 in the after-hours trading session.
  • Analysts expect Northern Technologies International Corporation (NASDAQ:NTIC) to post quarterly earnings at 18 cents per share on revenue of $21 million before the opening bell. Northern Technologies shares gained 2% to $12.55 in after-hours trading.

Check This Out: Cramer Says This Is An ‘Interesting, Good’ Stock: ‘I Think At $14, You Should Be A Buyer’

 

Total
0
Shares
Related Posts
Read More

CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal

Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will commercialise Avicanna's RHO Phyto brand in Europe for the first time. The company praised its own proprietary patent-protected technologies being entered into "the European market without competition" as testament to its "scientific and technical leadership in the cannabinoid clinical and commercialisation field", highlighting the deal's strategic nature and geographic position, as well as the expected rapid expansion into other European countries. The unnamed pharmaceutical company manufactures and markets a wide range of pharmaceuticals across four continents and has established a commercial infrastructure in Europe. These manufacturing plants will produce Avicanna's Ultra-CBD cream and CBG Transdermal Gel in 2024.

AVCNF